Qol Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and Fiscal Year Ending March 31, 2024
May 11, 2023 at 02:30 am EDT
Share
Qol Holdings Co., Ltd. provided consolidated earnings guidance for the six months ending September 30, 2023 and fiscal year ending March 31, 2024. For the six months, the company expects net sales to be JPY 85,600 million, operating profit to be JPY 3,500 million, profit attributable to owners of parent to be JPY 1,800 million and basic earnings per share to be JPY 48.68.
For the fiscal year, the company expects net sales to be JPY 180,000 million, operating profit to be JPY 10,000 million, profit attributable to owners of parent to be JPY 5,500 million and basic earnings per share to be JPY 148.74.
Qol Holdings Co.,Ltd., formerly Qol Co., Ltd. is engaged in the operation of insurance pharmacies and Business Process Outsourcing (BOP) commission business. The Company operates in two segments. The Insurance Pharmacy segment is engaged in the operation of insurance pharmacies, as well as the operation of convenience stores in hospitals. The BOP Commission segment is engaged in the Contract Sales Organization (CSO) business, Contract Research Organization (CRO) business, medical related business and the wholesale of medicine products, cosmetic products and daily necessities through its subsidiaries.